The Centers for Disease Control and Prevention (CDC) recently confirmed that Chagas disease poses an endemic risk for certain U.S. populations. This announcement has reignited scientific interest in ivermectin, particularly as researchers explore its potential role in parasite management and broader tropical disease prevention strategies. Public health authorities, advocacy groups, and medical...

The year 2025 has brought new waves of discussion in U.S. healthcare. With major CDC leadership changes under way, vaccine recommendations and drug policies are once again under scrutiny. Among the most controversial names resurfacing is Ivermectin, a drug that continues to divide the medical community and ignite passionate political debate. This article explores the latest...